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What is known on this topic: 
 
 
• Hypertension is a leading antecedent to a range of chronic and 
complex conditions, including renal disease, cardiovascular 
conditions and stroke. 
 
• Nurses in primary care are well positioned to support individuals to 
improve BP through the modification of lifestyle risk factors and 
adherence to evidence-based guidelines. 
 
• Currently there is insufficient evidence of the effect of nurse led 
interventions on health outcomes, like hypertension in the primary 
care setting. 
 
 
 
 
What this paper adds: 
 
 
• This paper outlines the protocol for a trial to target general practice 
patients most at risk of a CVD event to improve blood pressure and 
reduce lifestyle risk. 
 
• Health outcomes measures, including lifestyle risk factors, body 
mass index, medication adherence and blood pressure will be 
gathered at baseline, six and twelve months. 
 
• This novel intervention utilises the GPN role to top of their scope of 
practice, directing proactive, tailored BP management towards a 
population at high risk of CVD. 
 
 Abstract  
Background 
Hypertension is a preventable factor for cardiovascular disease (CVD), the leading cause 
of death globally. When hypertension is present with tobacco smoking, poor nutrition, 
physical inactivity or excessive alcohol consumption risk of CVD is increased. Given the 
prolonged engagement and ongoing relationship with patients, general practice nurses 
(GPNs) are ideally situated to actively engage with patients about optimal blood pressure 
control and lifestyle risk reduction.  
Objectives 
This study will test the effectiveness of a GPN-led intervention to reduce blood pressure in 
adults with hypertension and high cardiovascular risk. 
Design 
A multi-site, cluster randomised control trial (RCT) where the general practice is the unit of 
randomisation. 
Methods 
General Practices (n=20) will be block randomised to the intervention or usual care group. 
Adults with hypertension and high cardiovascular risk will be identified through an audit of 
electronic medical records and invited to attend an assessment visit. Eligible consenting 
patients will be recruited to the study. The intervention involves three face-to-face 
consultations and two telephone consultations with the nurse to assess lifestyle risk and 
develop an action plan. An appointment with the general practitioner (GP) will optimise 
pharmacotherapy. The primary outcome is blood pressure (BP), with secondary outcomes 
of lifestyle risk factors; smoking, nutrition, alcohol and physical activity (SNAP) body mass 
index (BMI) and medication adherence. Patients will have outcome measures evaluated at 
6 and 12 months.  
Discussion 
ImPress is innovative in its proactive approach of identifying those at greatest risk of CVD 
and using the emerging role of the GPN to target care towards improved BP control. If 
successful, findings from this trial could enhance the nursing role, improve health 
outcomes, inform health policy and provide an evidence base from which to transform 
blood pressure management in general practice.    
 
Trial Registration 
This RCT has been registered with the Australian and New Zealand Clinical Trials Registry 
as ACTRN12618000169246 
 
 
 
 
 
 
 
  
What is known on this topic: 
• Hypertension is a leading antecedent to a range of chronic and complex conditions, 
including renal disease, cardiovascular conditions and stroke. 
• Nurses in primary care are well positioned to support individuals to improve BP 
through the modification of lifestyle risk factors and adherence to evidence-based 
guidelines.  
• Currently there is insufficient evidence of the effect of nurse led interventions on 
health outcomes, like hypertension in the primary care setting. 
 
What this paper adds: 
• This paper outlines the protocol for a trial to target general practice patients most at 
risk of a CVD event to improve blood pressure and reduce lifestyle risk. 
• Health outcomes measures, including lifestyle risk factors, body mass index, 
medication adherence and blood pressure will be gathered at baseline, six and 
twelve months. 
• This novel intervention utilises the GPN role to top of their scope of practice, 
directing proactive, tailored BP management towards a population at high risk of 
CVD.  
 
  
1. Background 
Hypertension causes more deaths and disease than any other biomedical risk factor 
(National Heart Foundation of Australia, 2016). While effective pharmacotherapy and 
treatment exists, many of the 1 billion people worldwide estimated to have hypertension 
struggle to maintain optimal blood pressure (Mills et al., 2016). Uncontrolled high blood 
pressure places individuals at greater risk of developing life limiting diseases including 
renal failure, cerebrovascular accident and CVD (Cadilhac et al., 2012). When 
hypertension is present in combination with other modifiable risk factors such as abnormal 
blood lipids, elevated blood glucose, tobacco use, obesity, alcohol consumption, physical 
inactivity and nutritionally inadequate diet, the absolute risk of a CVD event is further 
increased (Blood Pressure Lowering Treatment Trialists' Collaboration, 2014, Sundström 
and Neal, 2015). People who fall into this high risk group have the most to gain from 
improved blood pressure control. 
Lowering blood pressure by as little as 1-2mmHg can reduce the morbidity and mortality 
associated with developing CVD (National Vascular Disease Prevention Alliance, 2012, 
Verdecchia et al., 2010). In addition, lifestyle modification can effectively delay or prevent 
the occurrence of hypertension, reduce existing high blood pressure and in some cases 
abolish the need for antihypertensive medication (National Heart Foundation of Australia, 
2016). Given the global prevalence of hypertension and its impact on morbidity and 
mortality (Mills et al., 2016, Zhou et al., 2017), there is an opportunity to improve the 
management of BP within primary care. 
There is growing emphasis internationally on providing health care in the community 
where people live. Historically, primary care has been largely delivered by GPs however, a 
growing team of multidisciplinary health professionals has emerged in this environment 
(Kringos et al., 2010, The Royal Australian College of General Practitioners, 2018). While 
models of primary care vary internationally, it usually represents the first point in which 
individuals present their health issues for treatment and ongoing health management 
(Kringos et al., 2010). Despite the availability of effective pharmacotherapy and treatment 
guidelines, barriers to optimal hypertension management in primary care exist (Sundström 
and Neal, 2015). Sub optimal blood pressure control has been associated with therapeutic 
inertia, lack of structured self-management support and patient knowledge, beliefs and 
behaviours around antihypertensive medications (Khatib et al., 2014, Sundström and Neal, 
2015). Drawing on the professional expertise of other members of the primary care team, 
such as nurses, has been associated with enhanced care delivery (Sullivan et al., 2016) 
and could assist in overcoming these barriers (Stephen et al., 2018a, Zwar et al., 2017).  
The nursing workforce in general practice has grown significantly in recent decades along 
with international recognition that the role could be more fully utilised (Bauer and 
Bodenheimer, 2017, Halcomb et al., 2014, Merrick et al., 2014). Current models of general 
practice remain reactive, GP led care (Russell, 2018) with lack of role clarity, suboptimal 
collaboration and funding mechanisms contributing to the under-utilisation of nurses 
(Bauer and Bodenheimer, 2017, McInnes et al., 2015). Emerging evidence demonstrates 
nurse-led chronic disease management to be feasible and highly acceptable to consumers 
(Halcomb et al., 2015a, Halcomb et al., 2015b, Mahomed et al., 2012, Stephen et al., 
2018a, Stephen et al., 2018b). Given their professional scope of practice and prolonged 
engagement with consumers, primary care nurses are ideally placed to provide team 
based blood pressure management and risk factor reduction initiatives (Halcomb et al., 
2004, Halcomb et al., 2007b). While conceptually alluring, the true impact of nurse-led 
care on health outcomes such as blood pressure improvement remains uncertain (Authors 
own) (Halcomb et al., 2007b, Stephen et al., 2018b). Variability in intervention 
components, reported outcomes, methodological quality and sample size seen in previous 
RCTs eludes definitive conclusion (Authors own)(Halcomb et al., 2007a). Therefore, it is 
timely to conduct a robust cluster RCT to provide evidence about the impact of this kind of 
intervention on health outcomes.  
1.1 Aim/Hypothesis  
The primary objective of the ‘Improving blood pressure in Primary Care’ (ImPress) RCT is 
to determine the effect of the intervention on blood pressure. Secondary objectives are to 
evaluate the interventions’ impact on lifestyle risk factors; smoking, nutrition, alcohol and 
physical activity (SNAP), BMI and medication adherence. It is hypothesized that, at 6 and 
12 months follow-up, patients with uncontrolled hypertension who receive the ImPress 
intervention will have; lower blood pressure, fewer lifestyle risk factors (SNAP), reduced 
BMI and improved medication adherence. 
2. Methods 
2.1 Study design and setting 
This study is a multi-site cluster RCT. To prevent contamination between intervention and 
control groups, the unit of randomisation will be the primary care site (general practice). 
General practices will be eligible to participate if they employ at least one Registered 
Nurse, have computerised clinical software (Medical Director or Best Practice) and if both 
GP and the GPN are willing to participate. A registered nurse is a baccalaureate prepared 
nurse (or equivalent) who is registered with the Nursing and Midwifery Board of Australia 
(Nursing and Midwifery Board of Australia, 2016). Twenty general practices will be 
recruited across South Western Sydney and Illawarra / Shoalhaven based on their 
willingness to participate and adopt the intervention within their model of care. The trial will 
use CONSORT guidelines (Moher et al., 2012) to aid in transparency of reporting.  
2.2 Randomisation 
Practices will be assigned to the intervention or control group in block by a statistician 
independent to the research team. This block randomisation method will increase the 
probability of each group containing an equal number of participants (Efird, 2011).  
2.3 Sample size  
Intra-cluster correlation coefficients and design effects for the outcome measures of 
systolic BP, diet score, physical activity score and BMI will be calculated using data from 
the Health Improvement and Prevention study, (Fanaian et al., 2010). This study is a 
seminal investigation of cardiovascular disease in Australian general practice. The 
calculation is based on a predicted between person standard deviation of 8mmHg 
(Fanaian et al., 2010). This is a compromise between the high effect (14mmHg) seen in 
the pilot study (Authors own) and the clinically significant difference of 5mmHg, which 
would overly inflate the sample size.  
The pilot study has demonstrated that 10 participants per practice is achievable and 
feasible within the available resources (Authors own). Therefore, the calculation has 
considered a cluster size of 10 and an intra-cluster correlation coefficient of 0.063. Using 
these figures, 154 participants across 15 practices would be required. However, allowing 
for 30% dropout / loss to follow up, a total sample of 200 patients across 20 practices will 
be sought. At this sample size, the study will also be sufficiently powered to detect a 
clinically significant difference in diet score (0.6 units), physical activity score (0.8 units) 
and BMI (2 units) and improved medication adherence as measured by the Hill-Bone 
Scale (Kim et al., 2000) and the Brief Medication Questionnaire (BMQ)(Svarstad et al., 
1999).  
2.4 Participant eligibility criteria  
Patients will be eligible to participate if they are aged between 45 and 74 years, have a 
diagnosis of hypertension, are at high risk of a CVD event and have an office blood 
pressure greater than140/90 mmHg at the assessment visit (National Heart Foundation of 
Australia, 2008, National Heart Foundation of Australia, 2016). This age group was 
selected to align with the Royal Australian College of General Practitioners guidelines on 
absolute cardiovascular risk (Royal Australian College of General Practitioners, 2015). 
Additionally, participants need to have actively attended the participating general practice 
3 or more times in the last 2 years (Royal Australian College of General Practitioners, 
2015). High CVD risk is defined as CVD risk greater than 15% or the presence of CVD as 
per the National Vascular Disease Prevention Alliance (2012). The CVD risk calculation is 
based on the combination of risk factors present and determines the probability of a CVD 
event within the next 5 years. Participants who have insufficient medical record data to 
calculate CVD risk, or with no recorded blood lipids results within the last 5 years, will be 
excluded unless data can be collected. Patients will also be excluded if they have 
insufficient English or impaired mental capacity which impacts their ability to consent and 
participate in the study or if they have a concomitant terminal diagnosis. 
2.5 Patient recruitment 
Participating GPNs will conduct a structured electronic search of practice medical records 
to identify eligible patients. As clinical auditing tools and software systems vary across 
general practices, the research team will offer technical support as required.   
From the list of potentially eligible patients, fifty individuals will be mailed an invitation 
containing study information and details about attending an assessment appointment with 
the GPN. Following the invitation letter, GPNs will call potentially eligible patients to offer 
further information and also encourage participation opportunistically during routine visits. 
Flyers and notices displayed in waiting room and clinical areas will also be used to 
increase patient awareness of the study. If insufficient response is received from the first 
fifty potential participants after a four week period, a further fifty potential participants will 
be sent an invitation letter. Such recruitment  has been successfully utilized in other trials 
and was demonstrated to be feasible and acceptable in the pilot study (Thoma et al., 
2010)(Authors own). 
Potentially eligible patients will attend an assessment visit with the GPN to determine their 
eligibility and provide informed consent. If the office blood pressure exceeds 140/90mmHg 
at the assessment visit (National Heart Foundation of Australia, 2016) the patient will be 
invited to participate. Those patients who present for an assessment visit with a blood 
pressure less than 140/90mmHg, or who indicate that they do not wish to participate, will 
be thanked for their time and provided with written health information about cardiovascular 
health. Patient recruitment will continue across general practices until the desired sample 
size (n=200) is reached. Anticipated participant flow through the trial is depicted in Figure 
1. 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Fig 1 Predicted Patient Participant Flow  
2.6 Intervention  
ImPress aims to improve BP control for individuals at risk of CVD by combining a proactive 
care approach with the emerging role of the GPN. The intervention is based on the 5A’s 
and motivational interviewing to bolster self-management support (Glasgow et al., 2006, 
Halcomb, 2017, Miller et al., 2008). The initial GPN consultation will record baseline BP, 
biometric measurements and lifestyle risks and serves as a foundation from which rapport 
and shared understanding is built. Subsequent visits will focus on individualised action 
planning in partnership with the patient, goal setting and feedback on progress (Figure 2). 
Nurses have been provided with print resources on smoking, nutrition, alcohol and 
physical activity to visually aid lifestyle discussions with the patients. GPs will reinforce 
lifestyle information and provide medication optimisation in line with Australian 
hypertension guidelines (National Heart Foundation of Australia, 2008). 
Templates to structure each nursing assessment will be provided in hard copy and digital 
format. GPNs will be encouraged to collaborate with the participating GP(s) to share 
information around the nursing care being provided. 
 
 
Figure 2 The ImPress Intervention 
 
2.7 Pre-Intervention education 
GPNs in the intervention arm will be reimbursed for attending a 1-day education session 
prior to the commencement of patient recruitment. Experts in the field of chronic disease 
management will deliver content on study rationale and procedures, data collection, blood 
pressure management protocol, motivational interviewing techniques and goal setting. 
This education format was piloted previously and viewed by participants as a vital 
preparatory step for intervention implementation (Authors own). Ongoing nurse mentoring 
and support will be provided by the trial co-ordinator throughout the study. The research 
team will conduct telephone support initially on a weekly basis then monthly as the 
intervention progresses.   
2.8 Standard care 
GPNs in control practices will receive a funded three-hour training session at the study 
commencement by the trial co-ordinator. Information will be provided on study recruitment, 
conducting medical record searches, data collection measures and accurate BP 
measurement (National Heart Foundation of Australia, 2016). Patients assigned to the 
control group will receive usual care from their general practice during the study period. 
Following the conclusion of the data collection, GPNs from the control group practices will 
receive a half-day hypertension management education session and lifestyle guideline 
resources. 
2.9 Outcome assessment 
Outcomes will be assessed for all participants at baseline, 6 and 12 months after 
recruitment. The primary outcome measurement, blood pressure, will be recorded by the 
GPN using an automated office blood pressure device. The specific devices used in each 
practice will be checked to ensure that they are up to date with calibration schedules. 
Whilst there is debate surrounding the appropriateness of various methods of BP 
measurement (Leenen and Myers, 2015, Myers et al., 2014), this method has been 
chosen as it most closely resembles usual practice and so is practical and cost-effective. 
BMI will be calculated using the standardised method of dividing weight (in kilograms) by 
height (in metres squared)(National Heart Foundation of Australia, 2016). Both weight and 
height will be measured by the nurse using standard techniques. 
The tools used to collect survey data will be provided to participating patients in the waiting 
room prior to the GPN visit. Patients self-reported smoking, nutritional, alcohol and 
physical activity will be collected using the Australian Bureau of Statistics Health Survey 
(Australian Bureau of Statistics, 2013). Medication adherence will be assessed using the 
Hill-Bone Compliance Scale (Kim et al., 2000) and the BMQ (Svarstad et al., 1999). The 
10 item Hill-Bone Compliance Scale (Kim et al., 2000) measures sodium intake, 
appointment keeping and medication taking on a Likert scale with responses from 1 
(Never) to 4 (all of the time). Additionally, the BMQ is a 9-item tool comprised of a 5 items 
on medication regime, 2 items on beliefs of drug efficacy and disadvantages and a 2 item 
recall section around remembering difficulties (Svarstad et al., 1999). 
2.10 Data management 
Data will be stored in the short term at the participating practice in a secure location before 
being collected by the research team. Once returned, paper data will be stored in locked 
filing cabinets at the University of XXXX and electronic data on password protected 
computers. In line with the Australian Code for the Responsible Conduct of Research 
(National Health and Medical Research Council, 2007), these data will be stored for 5 
years following publication of findings. Findings will be presented in a way which ensures 
individual participants and general practices are non-identifiable. Only the researchers 
involved in this study will have access to the raw data.  
2.11 Statistical analysis 
Data will be entered into SPSS (IBM Corp, Released 2012) and checked for completeness 
and data entry errors. Subsequently, the data will be examined for differences between 
primary (BP) and secondary outcomes (BMI, medication adherence and lifestyle risk 
factors). Variables between patients will be explored within and across practices using a 
linear mixed model. The intra-cluster correlation coefficient, or the measure of relatedness 
between the data (Killip et al., 2004) will be calculated and published to aid future 
research. 
2.12 Ethics 
Human Research Ethics approval for the conduct of this trial has been gained from the 
Human Research Ethics Committee of the University of XXXX prior to commencing 
recruitment and data collection (Approval No ###).  
2.13 Dissemination strategy 
Findings will be submitted for publication in relevant, high impact peer reviewed journals. 
Social media platforms such as Twitter and Facebook will be used to further amplify 
research impact globally to online communities. Results will also be of interest to clinical 
and academic audiences therefore the research team plan to disseminate findings at 
relevant professional conferences internationally. Participating patients, practices and key 
stakeholders will be informed of results in plain English via newsletters and presentations 
at local clinical and research meetings. 
3. Discussion 
Improving hypertension management in primary care is very important given the 
implications of unresolved high blood pressure. Targeting those most at risk, by selecting 
individuals at high CVD risk, represents an innovative proactive strategy rather than simply 
being reactive to adverse health outcomes. Utilising the GPN to direct the intervention 
capitalizes on their relationships with patients to achieve lifestyle risk reduction (Halcomb 
et al., 2004), while encouraging them to practice at the top of their scope of practice has 
the potential for economic benefits,  improved job satisfaction and retention (Halcomb et 
al., 2018). Although utilizing the role of the GPN in this area is conceptually alluring, the 
effectiveness of nurse-directed interventions upon health outcomes is not well established 
(Authors own). This study will provide robust evidence of the impact of a nurse-directed 
intervention for blood pressure management in high risk general practice patients. Results 
from this RCT could change the way in which hypertension care is organized and 
delivered in Australian general practice. 
This study is underpinned by a robust theoretical foundation. Elements of the Chronic Care 
Model (Wagner et al., 1996) have been embedded into intervention design to foster self-
management support and enhance delivery of targeted, person-centered BP management. 
Previous interventions have employed evidence based strategies namely the 5A’s 
Framework (Zwar et al., 2015) and Motivational Interviewing (Ma et al., 2014, Song et al., 
2014) to assist patients in self-management support. GPNs in the ImPress trial will be 
equipped to apply the 5A’s in conjunction with Motivational Interviewing techniques to 
enhance their ability to set goals and support patients embarking on lifestyle behavior 
change.  
ImPress also leverages a contextual advantage in terms of financial sustainability. 
Currently, nurse activity in general practices is supported by annual Australian 
Government funding (Australian Govenment, 2018). While a fee for service 
funding system operates in Australian primary care, moves towards block funding 
(McKittrick and McKenzie, 2018) and wider calls to reform to integrative, team 
orientated models could further enhance the nursing role (McInnes et al., 2016, 
Russell, 2018).  
Despite these significant strengths, a trial of this nature comes with methodological 
challenges. Recruitment across 20 geographically dispersed sites could prove challenging 
given the well reported engagement, recruitment and retention issues associated with 
multi-center RCTs in primary care (Heal et al., 2018). Therefore, there is potential that 
predicted sample size may not be achieved. To mitigate this, sample size calculations 
have allowed for a 30% drop out rate and extra support from the research team will be 
offered to practices experiencing difficulties with intervention implementation and delivery. 
While research in general practice is necessary to improve service delivery and 
enhance evidence based patient care, barriers to participation have been 
identified. The Australian fee-for-service system, time pressures and poor financial 
incentives for research activities are regularly cited factors that influence 
participation refusal (Brodaty et al., 2013, Heal et al., 2018, McKinn et al., 2015). In 
an effort to overcome these barriers, ImPress has been designed to ensure that 
minimal financial, time and workload burdens are associated with intervention 
implementation and delivery. Education sessions, data collection and consultations 
undertaken by nurses will be reimbursed at regular intervals throughout the 
intervention.  
To mitigate implementation issues and support problem solving, regular contact between 
clinicians and the research team will be maintained. Given the potential for variability 
between practice workplaces and styles, a process evaluation will be conducted at study 
conclusion to uncover the contextually specific barriers and enablers to the intervention.  
True multidisciplinary primary care research is vital to enhance professional knowledge 
and patient care. This study is innovative in its approach to proactively managing a 
common, but clinically significant health problem in primary care. Results will inform health 
policy, clinical practice, professional education and models of multidisciplinary care in 
general practice. 
  
Conflicts of interest 
Nil. 
 
Funding 
This study is funded by an Australian Government Research Training Program 
Scholarship   
 
Ethical approval 
This study was approved by the Human Research Ethics Committee of the XXXXX 
(Approval No. XXX). 
 
Acknowledgments 
Authors gratefully acknowledge the nurses, GPs and patients who participated in 
this study. 
References  
Australian Bureau of Statistics, 2013. Australian Health Survey: Updated Results, 2011-2012 4364.0.55.003. 
Latest Issue Released at 11:30 AM (CANBERRA TIME) 07/06/2013. 
Australian Govenment, 2018. Practice Nurse Incentive Program. 
Bauer, L., Bodenheimer, T., 2017. Article: Expanded roles of registered nurses in primary care delivery of 
the future. Nursing Outlook 65, 624-632. 
Blood Pressure Lowering Treatment Trialists' Collaboration, 2014. Blood pressure-lowering treatment 
based on cardiovascular risk: a meta-analysis of individual patient data. In: Lancet. pp. 591-598. 
Brodaty, H., Gibson, L.H.R., Waine, M.L., Shell, A.M., Lilian, R., Dimity, C., 2013. Research in general 
practice: a survey of incentives and disincentives for research participation. Mental Health in Family 
Medicine 10 (3), 163-173. 
Cadilhac, D.A., Carter, R., Thrift, A.G., Dewey, H.M., 2012. Organized blood pressure control programs to 
prevent stroke in australia: would they be cost-effective? Stroke 43 (5), 1370-1375. 
Efird, J., 2011. Blocked Randomization with Randomly Selected Block Sizes. International Journal of 
Environmental Research and Public Health 8 (1), 15-20. 
Fanaian, M., Laws, R.A., Passey, M., McKenzie, S., Wan, Q., Davies, G.P., Lyle, D., Harris, M.F., 2010. Health 
improvement and prevention study (HIPS) - evaluation of an intervention to prevent vascular 
disease in general practice. BMC Family Practice 11, 10p-10p. 
Glasgow, R.E., Emont, S., Miller, D.C., 2006. Assessing delivery of the five ‘As’ for patient-centered 
counseling. Health Promotion International 21 (3), 245-255. 
Halcomb, E., 2017. An Introduction to Community and Primary Health Care. In: Guzys, D., Brown, R., 
Halcomb, E., Whitehead, D. (Eds.), . Cambridge University Press, University Printing House, 
Cambridge. 
Halcomb, E., Davies, D., Salamonson, Y., 2015a. Consumer satisfaction with practice nursing: A cross-
sectional survey in New Zealand general practice. Australian Journal of Primary Health 21 (3), 347–
353. 
Halcomb, E., Moujalli, S., Griffiths, R., Davidson, P., 2007a. Effectiveness of general practice nurse 
interventions in cardiac risk factor reduction among adults. International Journal of Evidence-Based 
Healthcare 5 (3), 269-295. 
Halcomb, E., Smyth, E., McInnes, S., 2018. Job satisfaction and career intentions of registered nurses in 
primary health care: An integrative review. BMC Family Practice 19 (136), 
https://doi.org/10.1186/s12875-12018-10819-12871. 
Halcomb, E.J., Davidson, P., Daly, J., Yallop, J., Tofler, G., 2004. Australian nurses in general practice based 
heart failure management: Implications for innovative collaborative practice. European Journal of 
Cardiovascular Nursing 3 (2), 135-147. 
Halcomb, E.J., Moujalli, S., Griffiths, R., Davidson, P.M., 2007b. Effectiveness of general practice nurse 
interventions in cardiac risk factor reduction amongst adults: A systematic review. International 
Journal of Evidence-Based Healthcare 5 (3), 269-295. 
Halcomb, E.J., Salamonson, Y., Cook, A., 2015b. Satisfaction and comfort with nursing in Australian general 
practice. Collegian 22 (2), 199-205. 
Halcomb, E.J., Salamonson, Y., Davidson, P.M., Kaur, R., Young, S.A.M., 2014. The evolution of nursing in 
Australian general practice: a comparative analysis of workforce surveys ten years on. BMC Family 
Practice 15 (52), http://www.biomedcentral.com/1471-2296/1415/1452. 
Heal, C., Banks, J., Divakaran, P., Buttner, P., 2018. Building a bridge from the swamp to the ivory tower: 
Conducting randomised controlled trials in general practice. Australian Journal Of General Practice 
47 (3), 153-157. 
IBM Corp, Released 2012. IBM SPSS Statistics for Windows. Version 21.0 Armonk (IBM Corp). 
Khatib, R., Schwalm, J.D., Yusuf, S., Haynes, R.B., McKee, M., Khan, M., Nieuwlaat, R., 2014. Patient and 
healthcare provider barriers to hypertension awareness, treatment and follow up: A systematic 
review and meta-analysis of qualitative and quantitative studies. PLOS one 9 (1), 1-13. 
Killip, S., Mahfoud, Z., Pearce, K., 2004. What is an intracluster correlation coefficient? Crucial concepts for 
primary care researchers. Annals Of Family Medicine 2 (3), 204-208. 
Kim, M.T., Hill, M.N., Bone, L.R., Levine, D.M., 2000. Development and Testing of the Hill‐Bone Compliance 
to High Blood Pressure Therapy Scale. Progress in Cardiovascular Nursing 15 (3), 90-96. 
Kringos, D.S., Boerma, W.G., Bourgueil, Y., Cartier, T., Hasvold, T., Hutchinson, A., Lember, M., Oleszczyk, 
M., Pavlic, D.R., Svab, I., Tedeschi, P., Wilson, A., Windak, A., Dedeu, T., Wilm, S., 2010. The 
european primary care monitor: structure, process and outcome indicators. BMC Family Practice 11 
(1), 81. 
Leenen, F., Myers, M.G., 2015. AUTOMATED OFFICE BLOOD PRESSURE MEASUREMENT IN THE 
MANAGEMENT OF HYPERTENSION - FOURTH IN SERIES. E-Journal of Cardiology Practice 13 (15). 
Ma, C., Zhou, Y., Zhou, W., Huang, C., 2014. Evaluation of the effect of motivational interviewing 
counselling on hypertension care. Patient Education & Counseling 95 (2), 231-237. 
Mahomed, R., St John, W., Patterson, E., 2012. Understanding the process of patient satisfaction with 
nurse‐led chronic disease management in general practice. Journal of Advanced Nursing 68 (11), 
2538-2549. 
McInnes, S., Peters, K., Bonney, A., Halcomb, E., 2016. The influence of funding models on collaboration in 
Australian general practice. Australian Journal of Primary Health online early, 10.1071/PY16017. 
McInnes, S., Peters, K., Bonney, A., Halcomb, E., 2015. An integrative review of facilitators and barriers 
influencing collaboration and teamwork between general practitioners and nurses working in 
general practice. Journal of Advanced Nursing 71 (9), 1973-1985. 
McKinn, S., Bonner, C., Jansen, J., McCaffery, K., 2015. Recruiting general practitioners as participants for 
qualitative and experimental primary care studies in Australia. Australian Journal of Primary Health 
21 (3), 354-359. 
McKittrick, R., McKenzie, R., 2018. A narrative review and synthesis to inform health workforce preparation 
for the Health Care Homes model in primary healthcare in Australia. Australian Journal of Primary 
Health 24 (4), 317-312. 
Merrick, E., Fry, M., Duffield, C., 2014. Australian practice nursing: collaboration in context. Journal of 
Clinical Nursing 23 (23/24), 3525-3532. 
Miller, W.R., Butler, C.C., Aloia, M.S., 2008. Motivational Interviewing in Health Care: Helping Patients 
Change Behavior AU - Rollnick, Stephen. COPD: Journal of Chronic Obstructive Pulmonary Disease 5 
(3), 203-203. 
Mills, K.T., Bundy, J.D., Kelly, T.N., Reed, J.E., Kearney, P.M., Reynolds, K., Chen, J., He, J., 2016. Global 
Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based 
Studies From 90 Countries. Circulation 134 (6), 441-450. 
Moher, D., Hopewell, S., Schulz, K.F., Montori, V., Gøtzsche, P.C., Devereaux, P.J., Elbourne, D., Egger, M., 
Altman, D.G., 2012. Guideline: CONSORT 2010 explanation and elaboration: Updated guidelines for 
reporting parallel group randomised trials. International Journal of Surgery 10, 28-55. 
Myers, M.G., Kaczorowski, J., Dawes, M., Godwin, M., 2014. Automated office blood pressure 
measurement in primary care. Canadian Family Physician Medecin De Famille Canadien 60 (2), 127-
132. 
National Health and Medical Research Council, 2007. Australian code for the responsible conduct of 
research. Canberra. 
National Heart Foundation of Australia, 2008. Guide to management of hypertension 2008. Assessing and 
managing raised blood pressure in adults. Updated December 2010. 
National Heart Foundation of Australia, 2016. Guideline for the diagnosis and management of hypertention 
in adults - 2016. In: National Heart Foundation of Australia,. Melbourne. 
National Vascular Disease Prevention Alliance, 2012. Guidelines for the management of Absolute 
cardiovascular disease risk. 
Nursing and Midwifery Board of Australia, 2016. Registered Nurses Standards for Practice. 
Royal Australian College of General Practitioners, 2015. Standards for general practices (4th edition). East 
Melbourne, VIC, Australia. 
Russell, G., 2018. Contextual levers for team-based primary care: lessons from reform interventions in five 
jurisdictions in three countries. Family practice 35 (3), 276-284. 
Song, D., Xu, T.-Z., Sun, Q.-H., 2014. Effect of motivational interviewing on self-management in patients 
with type 2 diabetes mellitus: A meta-analysis. International Journal of Nursing Sciences 1 (3), 291-
297. 
Stephen, C., Halcomb, E., McInnes, S., Hermiz, O., Zwar, N., 2018a. Feasibility and acceptability of a nurse-
led hypertension management intervention in general practice. Collegian 25 (1), p33-38. 
Stephen, C., McInnes, S., Halcomb, E., 2018b. The feasibility and acceptability of nurse‐led chronic disease 
management interventions in primary care: An integrative review. Journal of Advanced Nursing 74 
(2), 279-288. 
Sullivan, E.E., Ibrahim, Z., Ellner, A.L., Giesen, L.J., 2016. Management Lessons for High-Functioning Primary 
Care Teams. Journal of Healthcare Management 61 (6), 449-466. 
Sundström, J., Neal, B., 2015. Replacing the hypertension control paradigm with a strategy of 
cardiovascular risk reduction. European Heart Journal - Quality of Care and Clinical Outcomes 1 (1), 
17-22. 
Svarstad, B.L., Chewning, B.A., Sleath, B.L., Claesson, C., 1999. The brief medication questionnaire: A tool 
for screening patient adherence and barriers to adherence. Patient Education and Counseling 37 
(2), 113-124. 
The Royal Australian College of General Practitioners, 2018. General Practice: Health of the Nation 2018. 
RACGP, East Melbourne, Vic. 
Thoma, A., Farrokhyar, F., McKnight, L., Bhandari, M., 2010. Practical tips for surgical research: how to 
optimize patient recruitment. Canadian journal of surgery. Journal canadien de chirurgie 53 (3), 
205-210. 
Verdecchia, P., Gentile, G., Angeli, F., Mazzotta, G., Mancia, G., Reboldi, G., 2010. Influence of blood 
pressure reduction on composite cardiovascular endpoints in clinical trials. J Hypertens 28 (7), 
1356-1365. 
Wagner, E.H., Austin, B.T., Von Korff, M., 1996. Organizing care for patients with chronic illness. Milbank 
Quarterly 74 (4), 511-544. 
Zhou, B., Bentham, J., Di Cesare, M., Bixby, H., Danaei, G., Cowan, M.J., Paciorek, C.J., Singh, G., 
Hajifathalian, K., Bennett, J.E., Taddei, C., Bilano, V., Carrillo-Larco, R.M., Djalalinia, S., Khatibzadeh, 
S., Lugero, C., Peykari, N., Zhang, W.Z., Lu, Y., Stevens, G.A., Riley, L.M., Bovet, P., Elliott, P., Gu, D., 
Ikeda, N., Jackson, R.T., Joffres, M., Kengne, A.P., Laatikainen, T., Lam, T.H., Laxmaiah, A., Liu, J., 
Miranda, J.J., Mondo, C.K., Neuhauser, H.K., Sundström, J., Smeeth, L., Soric, M., Woodward, M., 
Ezzati, M., Abarca-Gómez, L., Abdeen, Z.A., Rahim, H.A., Abu-Rmeileh, N.M., Acosta-Cazares, B., 
Adams, R., Aekplakorn, W., Afsana, K., Aguilar-Salinas, C.A., Agyemang, C., Ahmadvand, A., Ahrens, 
W., Al Raddadi, R., Al Woyatan, R., Ali, M.M., Alkerwi, A.a., Aly, E., Amouyel, P., Amuzu, A., 
Andersen, L.B., Anderssen, S.A., Ängquist, L., Anjana, R.M., Ansong, D., Aounallah-Skhiri, H., Araújo, 
J., Ariansen, I., Aris, T., Arlappa, N., Aryal, K., Arveiler, D., Assah, F.K., Assunção, M.C.F., Avdicová, 
M., Azevedo, A., Azizi, F., Babu, B.V., Bahijri, S., Balakrishna, N., Bandosz, P., Banegas, J.R., 
Barbagallo, C.M., Barceló, A., Barkat, A., Barros, A.J.D., Barros, M.V., Bata, I., Batieha, A.M., Baur, 
L.A., Beaglehole, R., Romdhane, H.B., Benet, M., Benson, L.S., Bernabe-Ortiz, A., Bernotiene, G., 
Bettiol, H., Bhagyalaxmi, A., Bharadwaj, S., Bhargava, S.K., Bi, Y., Bikbov, M., Bjerregaard, P., 
Bjertness, E., Björkelund, C., Blokstra, A., Bo, S., Bobak, M., Boeing, H., Boggia, J.G., Boissonnet, 
C.P., Bongard, V., Braeckman, L., Brajkovich, I., Branca, F., Breckenkamp, J., Brenner, H., Brewster, 
L.M., Bruno, G., Bueno-de-Mesquita, H.B., Bugge, A., Burns, C., Bursztyn, M., de León, A.C., 
Cacciottolo, J., Cameron, C., Can, G., Cândido, A.P.C., Capuano, V., Cardoso, V.C., Carlsson, A.C., 
Carvalho, M.J., Casanueva, F.F., Casas, J.-P., Caserta, C.A., Chamukuttan, S., Chan, A.W., Chan, Q., 
Chaturvedi, H.K., Chaturvedi, N., Chen, C.-J., Chen, F., Chen, H., Chen, S., Chen, Z., Cheng, C.-Y., 
Dekkaki, I.C., Chetrit, A., Chiolero, A., Chiou, S.-T., Chirita-Emandi, A., Cho, B., Cho, Y., Chudek, J., 
Cifkova, R., Claessens, F., Clays, E., Concin, H., Cooper, C., Cooper, R., Coppinger, T.C., Costanzo, S., 
Cottel, D., Cowell, C., Craig, C.L., Crujeiras, A.B., Cruz, J.J., D'Arrigo, G., d'Orsi, E., Dallongeville, J., 
Damasceno, A., Dankner, R., Dantoft, T.M., Dauchet, L., De Backer, G., De Bacquer, D., de Gaetano, 
G., De Henauw, S., De Smedt, D., Deepa, M., Dehghan, A., Delisle, H., Deschamps, V., Dhana, K., Di 
Castelnuovo, A.F., Dias-da-Costa, J.S., Diaz, A., Dickerson, T.T., Do, H.T.P., Dobson, A.J., 
Donfrancesco, C., Donoso, S.P., Döring, A., Doua, K., Drygas, W., Dulskiene, V., Džakula, A., Dzerve, 
V., Dziankowska-Zaborszczyk, E., Eggertsen, R., Ekelund, U., El Ati, J., Ellert, U., Elliott, P., Elosua, R., 
Erasmus, R.T., Erem, C., Eriksen, L., de la Peña, J.E., Evans, A., Faeh, D., Fall, C.H., Farzadfar, F., Felix-
Redondo, F.J., Ferguson, T.S., Fernández-Bergés, D., Ferrante, D., Ferrari, M., Ferreccio, C., 
Ferrieres, J., Finn, J.D., Fischer, K., Föger, B., Foo, L.H., Forslund, A.-S., Forsner, M., Fortmann, S.P., 
Fouad, H.M., Francis, D.K., Franco, M.d.C., Franco, O.H., Frontera, G., Fuchs, F.D., Fuchs, S.C., Fujita, 
Y., Furusawa, T., Gaciong, Z., Gareta, D., Garnett, S.P., Gaspoz, J.-M., Gasull, M., Gates, L., Gavrila, 
D., Geleijnse, J.M., Ghasemian, A., Ghimire, A., Giampaoli, S., Gianfagna, F., Giovannelli, J., 
Goldsmith, R.A., Gonçalves, H., Gross, M.G., Rivas, J.P.G., Gottrand, F., Graff-Iversen, S., Grafnetter, 
D., Grajda, A., Gregor, R.D., Grodzicki, T., Grøntved, A., Gruden, G., Grujic, V., Gu, D., Guan, O.P., 
Gudnason, V., Guerrero, R., Guessous, I., Guimaraes, A.L., Gulliford, M.C., Gunnlaugsdottir, J., 
Gunter, M., Gupta, P.C., Gureje, O., Gurzkowska, B., Gutierrez, L., Gutzwiller, F., Hadaegh, F., 
Halkjær, J., Hambleton, I.R., Hardy, R., Harikumar, R., Hata, J., Hayes, A.J., He, J., Hendriks, M.E., 
Henriques, A., Cadena, L.H., Herrala, S., Heshmat, R., Hihtaniemi, I.T., Ho, S.Y., Ho, S.C., Hobbs, M., 
Hofman, A., Dinc, G.H., Hormiga, C.M., Horta, B.L., Houti, L., Howitt, C., Htay, T.T., Htet, A.S., Hu, Y., 
Huerta, J.M., Husseini, A.S., Huybrechts, I., Hwalla, N., Iacoviello, L., Iannone, A.G., Ibrahim, M.M., 
Ikram, M.A., Irazola, V.E., Islam, M., Ivkovic, V., Iwasaki, M., Jackson, R.T., Jacobs, J.M., Jafar, T., 
Jamrozik, K., Janszky, I., Jasienska, G., Jelakovic, B., Jiang, C.Q., Joffres, M., Johansson, M., Jonas, 
J.B., Jørgensen, T., Joshi, P., Juolevi, A., Jurak, G., Jureša, V., Kaaks, R., Kafatos, A., Kalter-Leibovici, 
O., Kamaruddin, N.A., Kasaeian, A., Katz, J., Kauhanen, J., Kaur, P., Kavousi, M., Kazakbaeva, G., Keil, 
U., Boker, L.K., Keinänen-Kiukaanniemi, S., Kelishadi, R., Kemper, H.C.G., Kengne, A.P., Kersting, M., 
Key, T., Khader, Y.S., Khalili, D., Khang, Y.-H., Khaw, K.-T., Kiechl, S., Killewo, J., Kim, J., Klumbiene, J., 
Kolle, E., Kolsteren, P., Korrovits, P., Koskinen, S., Kouda, K., Koziel, S., Kristensen, P.L., Krokstad, S., 
Kromhout, D., Kruger, H.S., Kubinova, R., Kuciene, R., Kuh, D., Kujala, U.M., Kula, K., Kulaga, Z., 
Kumar, R.K., Kurjata, P., Kusuma, Y.S., Kuulasmaa, K., Kyobutungi, C., Laatikainen, T., Lachat, C., 
Lam, T.H., Landrove, O., Lanska, V., Lappas, G., Larijani, B., Laugsand, L.E., Laxmaiah, A., Bao, K.L.N., 
Le, T.D., Leclercq, C., Lee, J., Lee, J., Lehtimäki, T., Lekhraj, R., León-Muñoz, L.M., Levitt, N.S., Li, Y., 
Lilly, C.L., Lim, W.-Y., Lima-Costa, M.F., Lin, H.-H., Lin, X., Linneberg, A., Lissner, L., Litwin, M., 
Lorbeer, R., Lotufo, P.A., Lozano, J.E., Luksiene, D., Lundqvist, A., Lunet, N., Lytsy, P., Ma, G., Ma, J., 
Machado-Coelho, G.L.L., Machi, S., Maggi, S., Magliano, D.J., Majer, M., Makdisse, M., Malekzadeh, 
R., Malhotra, R., Rao, K.M., Malyutina, S., Manios, Y., Mann, J.I., Manzato, E., Margozzini, P., 
Marques-Vidal, P., Marrugat, J., Martorell, R., Mathiesen, E.B., Matijasevich, A., Matsha, T.E., 
Mbanya, J.C.N., Posso, A.J.M.D., McFarlane, S.R., McGarvey, S.T., McLachlan, S., McLean, R.M., 
McNulty, B.A., Khir, A.S.M., Mediene-Benchekor, S., Medzioniene, J., Meirhaeghe, A., Meisinger, C., 
Menezes, A.M.B., Menon, G.R., Meshram, I.I., Metspalu, A., Mi, J., Mikkel, K., Miller, J.C., Miquel, 
J.F., Mišigoj-Durakovic, M., Mohamed, M.K., Mohammad, K., Mohammadifard, N., Mohan, V., 
Yusoff, M.F.M., Møller, N.C., Molnár, D., Momenan, A., Mondo, C.K., Monyeki, K.D.K., Moreira, L.B., 
Morejon, A., Moreno, L.A., Morgan, K., Moschonis, G., Mossakowska, M., Mostafa, A., Mota, J., 
Motlagh, M.E., Motta, J., Muiesan, M.L., Müller-Nurasyid, M., Murphy, N., Mursu, J., Musil, V., 
Nagel, G., Naidu, B.M., Nakamura, H., Námešná, J., Nang, E.E.K., Nangia, V.B., Narake, S., Navarrete-
Muñoz, E.M., Ndiaye, N.C., Neal, W.A., Nenko, I., Nervi, F., Nguyen, N.D., Nguyen, Q.N., Nieto-
Martínez, R.E., Niiranen, T.J., Ning, G., Ninomiya, T., Nishtar, S., Noale, M., Noboa, O.A., Noorbala, 
A.A., Noorbala, T., Noto, D., Al Nsour, M., O'Reilly, D., Oh, K., Olinto, M.T.A., Oliveira, I.O., Omar, 
M.A., Onat, A., Ordunez, P., Osmond, C., Ostojic, S.M., Otero, J.A., Overvad, K., Owusu-Dabo, E., 
Paccaud, F.M., Padez, C., Pahomova, E., Pajak, A., Palli, D., Palmieri, L., Panda-Jonas, S., Panza, F., 
Papandreou, D., Parnell, W.R., Parsaeian, M., Pecin, I., Pednekar, M.S., Peer, N., Peeters, P.H., 
Peixoto, S.V., Pelletier, C., Peltonen, M., Pereira, A.C., Pérez, R.M., Peters, A., Petkeviciene, J., 
Pham, S.T., Pigeot, I., Pikhart, H., Pilav, A., Pilotto, L., Pitakaka, F., Plans-Rubió, P., Polakowska, M., 
Polašek, O., Porta, M., Portegies, M.L.P., Pourshams, A., Pradeepa, R., Prashant, M., Price, J.F., Puiu, 
M., Punab, M., Qasrawi, R.F., Qorbani, M., Radic, I., Radisauskas, R., Rahman, M., Raitakari, O., Raj, 
M., Rao, S.R., Ramachandran, A., Ramos, E., Rampal, S., Reina, D.A.R., Rasmussen, F., Redon, J., 
Reganit, P.F.M., Ribeiro, R., Riboli, E., Rigo, F., de Wit, T.F.R., Ritti-Dias, R.M., Robinson, S.M., 
Robitaille, C., Rodríguez-Artalejo, F., Rodriguez-Perez del Cristo, M., Rodríguez-Villamizar, L.A., 
Rojas-Martinez, R., Rosengren, A., Rubinstein, A., Rui, O., Ruiz-Betancourt, B.S., Horimoto, A.R.V.R., 
Rutkowski, M., Sabanayagam, C., Sachdev, H.S., Saidi, O., Sakarya, S., Salanave, B., Salazar Martinez, 
E., Salmerón, D., Salomaa, V., Salonen, J.T., Salvetti, M., Sánchez-Abanto, J., Sans, S., Santos, D., 
Santos, I.S., dos Santos, R.N., Santos, R., Saramies, J.L., Sardinha, L.B., Margolis, G.S., Sarrafzadegan, 
N., Saum, K.-U., Savva, S.C., Scazufca, M., Schargrodsky, H., Schneider, I.J., Schultsz, C., Schutte, 
A.E., Sen, A., Senbanjo, I.O., Sepanlou, S.G., Sharma, S.K., Shaw, J.E., Shibuya, K., Shin, D.W., Shin, 
Y., Siantar, R., Sibai, A.M., Silva, D.A.S., Simon, M., Simons, J., Simons, L.A., Sjöström, M., Skovbjerg, 
S., Slowikowska-Hilczer, J., Slusarczyk, P., Smeeth, L., Smith, M.C., Snijder, M.B., So, H.-K., Sobngwi, 
E., Söderberg, S., Solfrizzi, V., Sonestedt, E., Song, Y., Sørensen, T.I.A., Jérome, C.S., Soumare, A., 
Staessen, J.A., Starc, G., Stathopoulou, M.G., Stavreski, B., Steene-Johannessen, J., Stehle, P., Stein, 
A.D., Stergiou, G.S., Stessman, J., Stieber, J., Stöckl, D., Stocks, T., Stokwiszewski, J., Stronks, K., 
Strufaldi, M.W., Sun, C.-A., Sundström, J., Sung, Y.-T., Suriyawongpaisal, P., Sy, R.G., Tai, E.S., 
Tammesoo, M.-L., Tamosiunas, A., Tang, L., Tang, X., Tanser, F., Tao, Y., Tarawneh, M.R., Tarqui-
Mamani, C.B., Taylor, A., Theobald, H., Thijs, L., Thuesen, B.H., Tjonneland, A., Tolonen, H.K., 
Tolstrup, J.S., Topbas, M., Topór-Madry, R., Tormo, M.J., Torrent, M., Traissac, P., Trichopoulos, D., 
Trichopoulou, A., Trinh, O.T.H., Trivedi, A., Tshepo, L., Tulloch-Reid, M.K., Tuomainen, T.-P., 
Tuomilehto, J., Turley, M.L., Tynelius, P., Tzourio, C., Ueda, P., Ugel, E., Ulmer, H., Uusitalo, H.M.T., 
Valdivia, G., Valvi, D., van der Schouw, Y.T., Van Herck, K., van Rossem, L., van Valkengoed, I.G.M., 
Vanderschueren, D., Vanuzzo, D., Vatten, L., Vega, T., Velasquez-Melendez, G., Veronesi, G., 
Verschuren, W.M.M., Verstraeten, R., Victora, C.G., Viet, L., Viikari-Juntura, E., Vineis, P., Vioque, J., 
Virtanen, J.K., Visvikis-Siest, S., Viswanathan, B., Vollenweider, P., Voutilainen, S., Vrdoljak, A., 
Vrijheid, M., Wade, A.N., Wagner, A., Walton, J., Mohamud, W.N.W., Wang, M.-D., Wang, Q., 
Wang, Y.X., Wannamethee, S.G., Wareham, N., Wederkopp, N., Weerasekera, D., Whincup, P.H., 
Widhalm, K., Widyahening, I.S., Wiecek, A., Wijga, A.H., Wilks, R.J., Willeit, J., Willeit, P., Williams, 
E.A., Wilsgaard, T., Wojtyniak, B., Wong, T.Y., Wong-McClure, R.A., Woo, J., Woodward, M., Wu, 
A.G., Wu, F.C., Wu, S.L., Xu, H., Yan, W., Yang, X., Ye, X., Yiallouros, P.K., Yoshihara, A., Younger-
Coleman, N.O., Yusoff, A.F., Yusoff, M.F.M., Zambon, S., Zdrojewski, T., Zeng, Y., Zhao, D., Zhao, W., 
Zheng, Y., Zhu, D., Zimmermann, E., Zuñiga Cisneros, J., 2017. Worldwide trends in blood pressure 
from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 
million participants. The Lancet 389 (10064), 37-55. 
Zwar, N., Hermiz, O., Halcomb, E., Davidson, P., Bodenheimer, T., 2017. Improving blood pressure control in 
general practice: A pilot study of the ImPress intervention. Australian Family Physician 46 (5), 306. 
Zwar, N.A., Richmond, R.L., Halcomb, E.J., Furler, J.S., Smith, J.P., Hermiz, O., Blackberry, I.D., Jayasinghe, 
U.W., Borland, R., 2015. Quit in general practice: a cluster randomized trial of enhanced in-practice 
support for smoking cessation. Family Practice 32 (2), 173-180. 
 
